Price drops elsewhere, service degrades, your provider stops covering your state — there are plenty of good reasons to switch GLP-1 providers mid-treatment. The switch itself is straightforward. The gap, the records, and the billing overlap are where people get burned. Here's the clean sequence.
Key Takeaways
- Sign up with the new provider before canceling the old — approval isn't guaranteed, and a gap forces a re-titration.
- You are entitled to your records; at minimum, screenshot your current dose, titration history, and last-fill date before losing portal access.
- Tell the new provider your true current dose with evidence — 'continuity of care' beats 'new patient' titration restart.
- Watch the billing seam: cancel after the new provider approves you, but before the old one's next auto-ship charge date.
Step 1: Secure the New Before Releasing the Old
Complete the new provider's full intake as if starting fresh — because legally, you are. Their clinician must independently evaluate and prescribe; the previous prescription doesn't transfer. Only once you're approved and a first shipment is confirmed should you touch the old subscription. Patients who cancel first and apply second are the ones who end up with three-week gaps and a forced step-down.
Step 2: Carry Your Evidence
Before portal access dies, capture: current dose and how long you've been on it, full titration history, last fill date, and any labs in the portal. Formal record requests are your right and worth making — but screenshots are instant and sufficient for the core purpose, which is proving to the new clinician that you're an established patient at dose X, not a beginner.
Step 3: The Dose Conversation
A new provider who sees credible evidence of your current dose can typically continue it — this is ordinary continuity of care. Without evidence, their protocol may default you to a titration restart from 0.25mg, which is weeks of lost ground. Note that a conservative provider asking to verify before continuing a high dose is showing diligence, not obstruction; the red flag runs the other way — a provider happy to start anyone at 2.4mg no-questions-asked is a mill.
Step 4: Time the Billing Seam
Auto-ship programs bill on a cycle, and cancellation policies vary wildly — some require notice days before the next charge. The clean sequence: new provider approves → confirm old provider's next charge date → cancel in writing before it, keeping the confirmation. If a shipment was already charged, it's yours; consider it gap insurance.
Step 5: Mind the Formulation Seam
Switching providers often means switching pharmacies, and compounded products vary in concentration (mg/mL). Your dose in mg is what carries over — your injection volume in units may change. Confirm the new concentration and your new draw volume explicitly before the first injection from a new vial. This one check prevents the most dangerous class of switching error.
If You're Shopping Right Now
Gala
Injectable — $179/mo flat, every dose
Flat pricing at every dose — one of the simplest billing models in GLP-1 telehealth.
Compounded medications are not FDA-approved.
Visit Gala Paid linkWellorithm
Oral tablets — sema $147/mo, tirz $249/mo
Lowest published oral compounded pricing we track, tablets for both molecules.
Compounded medications are not FDA-approved.
Visit Wellorithm Paid linkLiv Body
Injectable GLP-1 program
Injectable-only telehealth program with provider review at intake.
Compounded medications are not FDA-approved.
Visit Liv Body Paid linkDone in this order, a switch costs you an hour of admin and zero missed doses. Done backwards, it costs three weeks and a re-titration. Order of operations is everything.
Affiliate disclosure: Links marked "Paid link" are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This supports our independent research.
Compounded medication notice: Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Brand-name alternatives (Wegovy, Ozempic, Zepbound, Rybelsus) are FDA-approved.
Medical disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs. Always consult a licensed healthcare provider about diagnosis, treatment, dosing, and whether these medications are appropriate for you.